Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs.
Shun JiangSisi WangQianqian WangChao DengYuhua FengFang MaJin'an MaXianling LiuChunhong HuTao HouPublished in: Cancer management and research (2021)
Our findings indicate that SIRI is an effective and convenient marker for predicting prognosis in advanced EGFR-mutant lung adenocarcinoma patients treated with first-generation TKI.